Drug
Who makes octreotide?
2 companies list octreotide as a human prescription drug, including under the names Mycapssa. Forms: capsule, delayed release. Routes: oral.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing octreotide
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Chiesi USA, Inc.Italy | capsule, delayed release | NDANDA208232 | 1 | 1 |
| Amryt Pharmaceuticals Designated Activity Company | capsule, delayed release | NDANDA208232 | 1 | 0 |
Bulk ingredient listings
- Ambiopharm, Inc.United States · 1 NDC
- BCN Peptides SASpain · 1 NDC
- Bachem Americas, Inc.United States · 1 NDC
- LSNE, Inc. · 1 NDC
- USV Private LimitedIndia · 1 NDC
Enquiry
Common questions
- Who makes octreotide?
- 2 companies list octreotide as a human prescription drug in the openFDA NDC Directory, led by Chiesi USA, Inc., Amryt Pharmaceuticals Designated Activity Company. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies octreotide active ingredient?
- 5 companies list octreotide as a bulk ingredient, including Ambiopharm, Inc., BCN Peptides SA, Bachem Americas, Inc., LSNE, Inc..